🔴 Recursion Pharmaceuticals is trading 5.1% down today as biotech sector weakens

Recursion Pharmaceuticals is trading at $3.23 (-5.13%) amid biotech-sector weakness.

• XBI is down 2.11%, alongside broader pressure from rising Treasury yields, elevated oil prices, and Federal Reserve uncertainty.
• The Nasdaq is down 0.72%, reinforcing the wider risk-off environment.
• Recursion Pharmaceuticals presented at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026; no company-specific negative announcement was identified.